Developing and Testing a Spanish-Language Intervention to Reduce Cancer-Related Sleep Disturbance
- Conditions
- Sleep Disturbance
- Interventions
- Behavioral: Spanish-language Cognitive-Behavioral Therapy for Insomnia (CBT-I) delivered via videoconference
- Registration Number
- NCT04101526
- Brief Summary
The purpose of this study is to learn about how to provide treatment to cancer survivors who have difficulty sleeping.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
- Located in the Southern Puerto Rico area
- Able to speak and read Spanish
- Have no documented or observable disabilities that would interfere with study participation
- Has completed primary treatment for breast cancer (e.g., surgery, chemotherapy, radiation)
- Has clinically significant sleep disturbance (i.e., >/= 8 on the Insomnia Severity Index)
- Is at low risk of other sleep disorders that are not amenable to treatment with cognitive-behavioral therapy
- Has access to the Internet and a digital device (e.g., smartphone) capable of using videoconference software
- Not able to read and speak Spanish
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SEQUENTIAL
- Arm && Interventions
Group Intervention Description Videoconference Spanish-language Cognitive-Behavioral Therapy for Insomnia (CBT-I) Spanish-language Cognitive-Behavioral Therapy for Insomnia (CBT-I) delivered via videoconference Behavioral: New Spanish-language Cognitive-Behavioral Therapy for Insomnia (CBT-I) delivered via videoconference
- Primary Outcome Measures
Name Time Method Recruitment Rate - Acceptability of New Intervention for Cancer-Related Sleep Disturbances Baseline The study will be deemed acceptable if β₯ 50% of eligible cancer survivors who are approached agree to participate. Recruitment rate will be measured by percentage of patients enrolled.
Self Report Outcome - Acceptability of New Intervention for Cancer-Related Sleep Disturbances Approximately 6 weeks after first intervention session The study will be deemed acceptable if \> 50% of intervention group participants report that, on average, they agree with positive statements about the intervention (i.e., report an average score of \>3 on a scale of 0 to 4).
Number of Participants Attending Educational Component - Feasibility of New Intervention for Cancer-Related Sleep Disturbances approximately 6 weeks after first intervention session The study will be deemed feasible if β₯ 75% of the intervention group participants attend at least half of the educational components of the intervention. This will be operationalized as having attended at least half of the sessions.
- Secondary Outcome Measures
Name Time Method Efficacy of New Intervention Using PSQI Scoring Baseline and approximately 6 weeks after first intervention session Pittsburgh Sleep Quality Index (PSQI) Scoring:
Duration of Sleep, Sleep Disturbance, Sleep Latency, Days of Disfunction due to Sleepiness, Sleep Efficiency, Overall Sleep Quality, and Meds Needed to Sleep Response Scale 0 (better) 3 (worse). Total Minimum Score 0 (Better), Total Maximum Score 21 (Worse)
β€ 5 = Good Sleep Quality \>5 = Poor Sleep QualityEfficacy of New Intervention Using ISI Scoring Baseline and approximately 6 weeks after first intervention session Insomnia Severity Index (ISI) Scoring:
Sleep Quality, Symptom Severity, Sleep Patterns, Daily Functioning, Insomnia Noticeable to Others, Level of Distress Caused by Insomnia Response Scale 0 (better) 4 (worse) Total Minimum Score 0 (Better) Total Maximum Score 28 (Worse)
0-7: No Clinically Significant Insomnia 8-14: Subthreshold Insomnia 15-21: Clinical Insomnia 22-28: Severe Clinical Insomnia
Trial Locations
- Locations (2)
H Lee Moffitt Cancer and Research Institute
πΊπΈTampa, Florida, United States
Ponce Health Services University
π΅π·Ponce, Puerto Rico